A President's Trust Traded Eli Lilly Stock While His Administration Expanded the Market for Its Drugs
Financial disclosures show hundreds of thousands of dollars invested in Eli Lilly on Trump's behalf while his administration expanded access to the company's obesity drugs. No law stops this — and that's the story.